Show 10 5 10 15 20 50 100 250 Sort by year (new to old) Actions News feed Embed this list Save this search Mark all Export Your filters: cql: author="Coutre, Steven" or (type exact bookEditor and editor="Coutre, Steven") Mark journalArticle A1 open access Sustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia : extended phase 3 results from RESONATE-2 Paul M Barr, Tadeusz Robak, Carolyn Owen, Alessandra Tedeschi, Osnat Bairey, Nancy L Bartlett, Jan A Burger, Peter Hillmen, Steven Coutre, Stephen Devereux, et al. (2018) HAEMATOLOGICA. 103(9). p.1502-1510 Mark conference C3 Updated efficacy and safety from the phase 3 resonate-2 study : ibrutinib as first-line treatment option in patients 65 years and older with chronic lymphocytic leukemia/small lymphocytic leukemia Paul Barr, Tadeusz Robak, Carolyn J Owen, Alessandra Tedeschi, Osnat Bairey, Nancy L Bartlett, Jan Burger, Peter Hillmen, Steven Coutre, Stephen Devereux, et al. (2016) BLOOD. 128(22). Mark conference C3 Results from the international, randomized phase 3 study of ibrutinib versus chlorambucil in patients 65 years and older with treatment-naive CLL/SLL (RESONATE-2 (TM)) Alessandra Tedeschi, Paul M Barr, Tadeusz Robak, Carolyn Owen, Paolo Ghia, Osnat Bairey, Peter Hillmen, Nancy L Bartlett, Jianyong Li, David Simpson, et al. (2015) BLOOD. 126(23).